Winnersh, United Kingdom

Steven Michael McAteer

This inventor holds 1 USPTO granted patent. Top assignee: Vernalis Research Limited. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven Michael McAteer. Retrieved from https://idiyas.com/inventor/steven-michael-mcateer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Steven Michael McAteer

Introduction

Steven Michael McAteer is a notable inventor based in Winnersh, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target glutamatergic transmission. His work is essential in addressing various neurological conditions.

Latest Patents

Steven holds a patent for 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission. This patent highlights his innovative approach to developing therapeutic agents that can potentially improve the quality of life for individuals suffering from related disorders. He has 1 patent to his name.

Career Highlights

Steven is currently employed at Vernalis Research Limited, where he continues to advance his research and development efforts. His role at the company allows him to collaborate with other talented scientists and contribute to groundbreaking projects in the pharmaceutical industry.

Collaborations

Throughout his career, Steven has worked alongside esteemed colleagues such as Suneel Gaur and Roger John Gillespie. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Steven Michael McAteer exemplifies the spirit of innovation in the realm of medicinal chemistry. His contributions, particularly in the development of new therapeutic agents, underscore the importance of research in improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…